Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China flag China · Delayed Price · Currency is CNY
40.80
+1.42 (3.61%)
Jul 31, 2026, 3:00 PM CST

SHA:688336 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2,9742,899704.58294.6149.318.06
Depreciation & Amortization
123.47123.47127.9796.08122.41135.46
Other Amortization
0.360.36----
Loss (Gain) From Sale of Assets
1.091.09-0.12-56.390.9412.98
Loss (Gain) From Sale of Investments
-99.77-99.77-411.59-3-19.98-20.93
Stock-Based Compensation
26.4626.466.97-6.282.5411.42
Provision & Write-off of Bad Debts
-0.26-0.26-0.23-6.795.491.22
Other Operating Activities
-401.87-74.03-77.49-35.913.68-20.61
Change in Accounts Receivable
23.7823.78-60.9315.4107.1-258.94
Change in Inventory
-30.46-30.46-35.0133.36--
Change in Accounts Payable
186.34186.3417.8363.469.24-67.49
Change in Unearned Revenue
-15.64-15.64-7.09-5.46-10.49-18.83
Operating Cash Flow
2,7913,043281.14416.35233.49-243.79
Operating Cash Flow Growth
899.80%982.55%-32.48%78.32%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-263.32-252.95-280.78-235.75-221.26-263.82
Sale of Property, Plant & Equipment
--0.69100.450.40.38
Investment in Securities
-2,866-3,058-953.98-366.5-725.89214
Other Investing Activities
207.32147.07483.9322.3730.0630.94
Investing Cash Flow
-2,922-3,164-750.14-479.42-916.69-18.5

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--5050150-
Total Debt Issued
--5050150-
Short-Term Debt Repaid
--50-50-150--
Total Debt Repaid
-50-50-50-150--
Net Debt Issued (Repaid)
-50-50--100150-
Issuance of Common Stock
15.3915.39--2.3-
Common Dividends Paid
-76.17-76.46-52.37-1.47-1.22-
Financing Cash Flow
-110.78-111.07-52.37-101.47151.08-

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
3.24.670.282.271.47-0.17
Net Cash Flow
-238.47-226.53-521.1-162.27-530.66-262.47

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,5272,7910.35180.6112.23-507.61
Free Cash Flow Growth
16578.80%787511.40%-99.80%1376.67%--
Free Cash Flow Margin
58.52%66.45%0.03%17.81%1.48%-54.65%
Free Cash Flow Per Share
2.803.11-0.200.01-0.58
Levered Free Cash Flow
-630.41,979-66.6346.51-14.48-394.76
Unlevered Free Cash Flow
-630.221,979-65.947.38-13.66-394.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
212.5844.2643.129.2424.5721.75
Change in Working Capital
166.83166.83-68.94134.0369.1-381.39